PMC:7113610 / 7592-7759 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"312","span":{"begin":51,"end":58},"obj":"Species"},{"id":"313","span":{"begin":150,"end":166},"obj":"Species"}],"attributes":[{"id":"A312","pred":"tao:has_database_id","subj":"312","obj":"Tax:9606"},{"id":"A313","pred":"tao:has_database_id","subj":"313","obj":"Tax:694009"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In 2001 the samples were isolated from the healthy persons of Hongkong and the molecular assessment showed 2.5% frequency rate of anti-bodies against SARS-coronavirus."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T78","span":{"begin":150,"end":166},"obj":"Disease"},{"id":"T79","span":{"begin":150,"end":154},"obj":"Disease"}],"attributes":[{"id":"A78","pred":"mondo_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A79","pred":"mondo_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"In 2001 the samples were isolated from the healthy persons of Hongkong and the molecular assessment showed 2.5% frequency rate of anti-bodies against SARS-coronavirus."}

{"project":"LitCovid-sentences","denotations":[{"id":"T57","span":{"begin":0,"end":167},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In 2001 the samples were isolated from the healthy persons of Hongkong and the molecular assessment showed 2.5% frequency rate of anti-bodies against SARS-coronavirus."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T197","span":{"begin":51,"end":58},"obj":"NCBITaxon:1"},{"id":"T198","span":{"begin":150,"end":154},"obj":"SP_10"},{"id":"T199","span":{"begin":155,"end":166},"obj":"NCBITaxon:11118"}],"text":"In 2001 the samples were isolated from the healthy persons of Hongkong and the molecular assessment showed 2.5% frequency rate of anti-bodies against SARS-coronavirus."}